Continuous monitoring of proteins a game-changer for patients with rapidly deteriorating conditions

Health
25 Jan 2021 7:06 am AEST Date Time
Share

Monash University

A world-first discovery by Australian researchers could become a game-changer for patients at risk of rapid health deterioration, such as heart complications, stroke, sepsis and cancer.

Researchers developed an antibody as a biosensor, to continuously monitor rapid changes in the concentration of EGFR, a protein present on cancer cells and in body fluids.

Traditional diagnostic tests involve sampling something tissue, blood or other bodily fluids, and taking it to a lab

/Public Release.

Are tomorrow’s engineers ready to face AI’s ethical challenges?

Getting a good night’s rest is vital for neurodiverse children – pediatric sleep experts explain why

Caring for older Americans’ teeth and gums is essential, but Medicare generally doesn’t cover that cost

Removing barriers to the rights of persons with albinism critical to improving lives, says UN expert: Lesotho

CIFAL Plock Promotes Road Safety and Launches Autosobriety Poland Platform

Saudi Arabia defeat Futsalroos in second AFC Futsal Asian Cup group game

Break And Enter Charges At Mansfield

Council On Track To Achieving Net Zero Emissions